Replies to post #128585 on Avid Bioservices Inc (CDMO)

[tarvacin]

All is good except the most important thing, market capitalization. But we do have hope. Hope that things will change.

[jakedogman1]

Yes...5 years and that's how long the problem has been lingering. Same with going concern... I do have as much experience in biotech as current board which is zero.... I have not run other public companies in the ground like current bod....

Where's a worse BOD? Anybody know of one?

[EYEBUYSTOX]

Rather than asking for credentials, you could simply look at the timing of other oncology deals as a comparator most of which occurred prior to phase II data or shortly thereafter.

THLD, PCYC are a few examples. One partnered on surrogate endpoint phase II data and the other partnered a few months before the phase III was set to begin. Both deals resulted in a market cap in excess of $1 billion.

I guess PPHM has 4-6 more months before they need to show the money. The ATM usage this quarter will be a good tell. If it's up a lot from last quarter I can't see that as a good sign.

[investingdog]

You are questioning credentials and business experience of the posters criticizing the management. These questions should be directed toward PPHM management. How many partnership deals has SK successfully negotiated so far? The answer is ZERO. So, according to your logic, anybody is as qualified as he is when it comes to negotiating deals with other entities.